ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

901–920 of 6,209 studies

Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study.

Piche, T, Vanbiervliet, G, Cherikh, F et al.·Gut·2005

This study tested whether a medication called ondansetron, which affects serotonin in the brain, could reduce fatigue in people with chronic hepatitis C. Thirty-six patients took either ondansetron or a placebo pill for one month and were then observed for another month. Ondansetron significantly improved fatigue scores by more than 30% within two weeks and maintained this improvement, while placebo did not.

Evidence Atlas

Evidence browser

Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study.

Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome.

Effect of psychiatric disorders on outcome of cognitive-behavioural therapy for chronic fatigue syndrome.

A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change.

Randomized controlled trial of Siberian ginseng for chronic fatigue.

Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome.

Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome.

Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Social support and the persistence of complaints in chronic fatigue syndrome.

Efficacy of cognitive-behavioural therapy by general practitioners for unexplained fatigue among employees: Randomised controlled trial.

Patient education to encourage graded exercise in chronic fatigue syndrome. 2-year follow-up of randomised controlled trial.

Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial.

Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatigue syndrome.

Quality of life and symptom severity for individuals with chronic fatigue syndrome: findings from a randomized clinical trial.

A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.

Biofeedback-based psychophysiological treatment in a primary care setting: an initial feasibility study.

A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.

Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.

Randomised controlled trial of graded exercise in chronic fatigue syndrome.

Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research